RPS6KB1 and vitiligo: Recently, our group demonstrated that, in vitiligo melanocytes, the expression of AMPK phosphorylated (pAMPK) was upregulated, whereas the phosphorylation level of the downstream target of mTORC1, S6 kinase (pS6K), was reduced [20], further supporting the impaired metabolic condition.